MedTrace Logo

Dietary Supplements and Middle Aged Women (Creatine)

NCT07729930 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-07-28

No results posted yet for this study

Summary

This study will examine the effects of combining different types of dietary supplements on various aspects of health and wellbeing in middle aged women. The main outcomes of the trial will be aspects of health and wellbeing that middle aged women report as increasingly problematic, such as joint pain, fatigue, sleep, and changes in body composition, strength, and inflammation. Participants will consume the supplement(s) or placebo for 8 weeks, and outcome measures will be assessed before and after supplementation.

Conditions

  • Cognition
  • Muscle Strength
  • Fatigue Symptom
  • Blood Pressure and Augmentation Index
  • Body Composition Changes
  • Sleep
  • Gastrointestinal Comfort
  • Quality of Life
  • Joint Pain
  • Inflammation Biomarkers
  • Bone Metabolism Biomarkers
  • Menopause Symptoms

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Creatine monohydrate for 8 weeks (\~6 g/day)

DIETARY_SUPPLEMENT

Placebo control

Maltodextrin for 8 weeks (\~10 g/day)

Sponsors & Collaborators

  • Loughborough University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2028-11-01
Completion
2028-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07729930 on ClinicalTrials.gov